Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? [electronic resource]
Producer: 20130220Description: 100-6 p. digitalISSN:- 1769-6917
- Adult
- Aged
- Aged, 80 and over
- Alkaline Phosphatase -- blood
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Bevacizumab
- Brain Neoplasms -- blood
- Cancer Care Facilities
- Carcinoma, Renal Cell -- blood
- Everolimus
- Female
- France
- Humans
- Indoles -- therapeutic use
- Kidney Neoplasms -- blood
- Male
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Proportional Hazards Models
- Pyridines -- therapeutic use
- Pyrroles -- therapeutic use
- Retrospective Studies
- Risk Factors
- Sirolimus -- analogs & derivatives
- Sorafenib
- Sunitinib
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.